Table of Contents Table of Contents
Previous Page  10 / 29 Next Page
Information
Show Menu
Previous Page 10 / 29 Next Page
Page Background

Euro Gastroenterology 2019 & Clinical Pharmacy 2019

Archives of General Internal Medicine | ISSN: 2591-7951 | Volume 3

Page 31

March 25-26, 2019 | Amsterdam, Netherlands

&

GASTROENTEROLOGY AND HEPATOLOGY

4

th

International Conference on

CLINICAL PHARMACY & PHARMACY PRACTICE

9

th

World Congress on

Joint Event on

OF EXCELLENCE

IN INTERNATIONAL

MEETINGS

alliedacademies.com

YEARS

COMPARISON OF QUANTITATIVE HEPATITIS B VIRUS DNA REAL TIME PCR

(RT-PCR) WITH REVERSE TRANSCRIPTION PCR (RT-PCR)

Rubi Ghazala

Lahore General Hospital, Pakistan

Background:

Serum HBV DNA is a useful and reliable marker to diagnose and monitor HBV infection. The lim-

itation of HBV DNA is that it is expensive and that the assays lack uniformity and standardization. Hence there is

a need for more economical and reliable marker. HBsAg quantitation is one such surrogate serological marker.

The objective of the current study is to compare the serum hepatitis B virus DNA quantitative Real Time PCR with

Hepatitis B reverse transcription PCR (rt-PCR).

Methods:

Patients with HBV attending to the outpatient clinic of all departments were enrolled in the study.

Patients with undetectable HBV DNA levels and those co-infected with HCV or HIV were excluded from the study.

All patients were tested for serological markers like HBsAg, HBeAg, and HBV DNA-PCR. HBsAg quantification was

done using conventional ELISA immunoassay. Chi-square was used to compare between HBV DNA (RT-PCR) and

(rt-PCR) quantitation. Statistical analysis was done using SPSS and P value of <0.05 was considered significant.

Results:

A total of 661 patients were enrolled in the study. Out of 373 serum samples were analyzed by HBV RT-

PCR while 281 by HBV rt-PCR. 38.9% were females in group of HBV RT-PCR while, 32.7% in group of HBV rt-PCR

and mean age of patients in the entire study group was 33.01 years in group of HBV RT-PCR while, 34.61 years in

group of HBV rt-PCR. The mean ALT level was 57.6 U/L in group of HBV RT-PCR while, 51.00 in group of HBV rt-

PCR. 16.5% (n=61) in group of HBV RT-PCR while, 8.9% (n=33) in group of HBV rt-PCR were HBeAg positive. 94.9%

(n=351) in group of HBV RT-PCR while, 73.2% (n=271) in group of HBV rt-PCR were HBsAg positive. Mean HBV

DNA Positive 44.3% in group of HBV RT-PCR while, 14.6% in group of HBV rt-PCR. HBV DNA (positive) levels were

significantly higher in HBV RT-PCR patients compared with HBV rt-PCR patients (164 versus 54; p=0.001). Neither

HBsAg levels nor HBeAg levels were significant (p=0.573, 0.057). HBV Real Time RT-PCR is best for diagnosis of

HBV DNA PCR. Clinical significant result obtained from such test. HBV RT-PCR has become a useful and important

technology for diagnosis of HBV DNA PCR, it must be used appropriately.

Conclusions:

There is a significant difference between HBV DNA Real Time PCR (RT-PCR) with HBV DNA reverse

transcription PCR (rt-PCR) patients with hepatitis B virus but not in HBsAg and HBeAg.

Keywords:

Hepatitis B Virus, Real Time PCR, reverse transcription PCR, HBsAg quantitation

Rubi Ghazala, Arch Gen Intern Med 2019, Volume 3 | DOI: 10.4066/2591-7951-C1-023